<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100927">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02037659</url>
  </required_header>
  <id_info>
    <org_study_id>Dermabond</org_study_id>
    <nct_id>NCT02037659</nct_id>
  </id_info>
  <brief_title>Dermabond Treatment for Gastric Variceal Bleeding</brief_title>
  <official_title>Endoscopic Ultrasound (EUS) Gastric Variceal Bleeding Database Repository</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of having a database is to collect data related to endoscopic ultrasound
      procedures performed by Indiana University EUS physicians; specifically, for the treatment
      of gastric variceal bleeding  This data will be used for research purposes only to determine
      the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding.   The
      physicians will also be able to better understand the patient's condition and disease
      process that may lead to improved standard of care and improved patient management.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical outcomes research is one of the strengths of the EUS group. As a group, the
      physicians need a tracking system for specific treatment modalities, and data to determine
      the impact of endoscopic ultrasound for patients with gastric variceal bleeding. Gastric
      variceal bleeding is a severe complication of portal hypertension with significant morbidity
      and mortality with limited therapeutic options.    Currently, there is no database in
      existence for endoscopic ultrasound clinical research for specific procedures.  Also, there
      is limited data regarding the outcome of endoscopic sclerotherapy with cyanoacrylate in the
      United States.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>36 Months</target_duration>
  <primary_outcome>
    <measure>To determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding.</measure>
    <time_frame>36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients with gastric variceal bleeding will be treated with DermaBond injection via EUS (endoscopic ultrasound). A follow-up EUS will observe the treated varices and determine if retreatment with DermaBond is necessary, or if observation alone is requried.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastric Varices</condition>
  <arm_group>
    <arm_group_label>Gastric Varices treatment</arm_group_label>
    <description>DermaBond (glue) treatment of Gastric Varices.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DermaBond treatment of Gastric Varices</intervention_name>
    <description>Endoscopic Ultrasound (EUS) administration of DermaBond glue to control bleeding gastric varices.</description>
    <arm_group_label>Gastric Varices treatment</arm_group_label>
    <other_name>DermaBond: (cyanoacrylate tissue adhesive).</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with DermaBond for gastric varices.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Anyone receiving treatment with DermaBond for treatment gastric varices.

        Exclusion Criteria:

        No evidence of gastric varices.

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John M. DeWitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathleen A. McGreevy, RN</last_name>
    <phone>317-944-5392</phone>
    <email>kmcgreev@iu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John M. DeWItt, MD</last_name>
    <phone>317-944-0880</phone>
    <email>jodewitt@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202-5121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John M. DeWitt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 14, 2014</lastchanged_date>
  <firstreceived_date>January 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
